免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

PubMed

泌尿科的人工智能:美國食品藥品管理局批准設備的評論。

PMID:42299919 ·

Z, h, i, y, u, , Q, i, a, n, ;, , P, i, e, t, r, o, , B, r, i, n, ;, , S, t, e, p, h, a, n, , K, o, r, n, ;, , A, n, d, r, e, a, , C, o, s, e, n, z, a, ;, , H, a, n, n, a, , Z, u, r, l, ;, , K, l, a, r, a, , P, o, h, l, ;, , J, i, n, a, , P, a, k, p, o, o, r, ;, , C, a, r, o, l, i, n, e, , M, , M, o, o, r, e, ;, , F, r, a, n, c, e, s, c, o, , G, i, g, a, n, t, i, ;, , Q, u, o, c, -, D, i, e, n, , T, r, i, n, h, ;, , A, l, e, x, a, n, d, e, r, , P, , C, o, l, e

期刊BJU international
年份
PMID42299919

摘要

To systematically characterise United States Food and Drug Administration (FDA) authorised urology-specific artificial intelligence (AI)-enabled medical devices and to evaluate the publicly available evidence supporting their authorisation. We reviewed the FDA AI-Enabled Medical Devices List. Devices cleared by September 2025 were manually screened for urological relevance using FDA clearance documents (e.g., 510(k), De Novo) to confirm clinical application. Eligible devices were categorised by

官方來源

在 PubMed 上查看 →

資料來自 PubMed / NCBI。全文與最新資訊請一律參閱官方紀錄。

↑